Prof. Dr. med. et phil. nat. Markus Jörger
Oberarzt Onkologie/Hämatologie
Mitarbeiter Wissenschaftliche Module CTU (Klinische Pharmakologie)
Leitende(r) Arzt/Ärztin
Medizinische Onkologie und Hämatologie · Dept. I
Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients
Jörger M, Huitema A, van den Bongard H, Baas P, Schornagel J, Schellens J, Beijnen J. Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients. British journal of clinical pharmacology 2006; 62:71-80.
01.07.2006Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients
01.07.2006British journal of clinical pharmacology 2006; 62:71-80
Jörger Markus, Huitema A D R, van den Bongard H J G D, Baas P, Schornagel J H, Schellens J H M, Beijnen J H
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma
Jermann M, Bauer J, Rhyner K, Egli F, Morant R, Gillessen Sommer S, Jörger M, Cerny T, Salzberg M, Stahel R, Pless M. A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma. Cancer chemotherapy and pharmacology 2006; 57:533-9.
01.04.2006A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma
01.04.2006Cancer chemotherapy and pharmacology 2006; 57:533-9
Jermann Monika, Bauer Jean A, Rhyner Kaspar, Egli Fritz, Morant Rudolf, Gillessen Sommer Silke, Jörger Markus, Cerny Thomas, Salzberg Marc, Stahel Rolf A, Pless Miklos
Quantitative effect of gender, age, liver function, and body size on the population pharmacokinetics of Paclitaxel in patients with solid tumors
Jörger M, Huitema A, van den Bongard D, Schellens J, Beijnen J. Quantitative effect of gender, age, liver function, and body size on the population pharmacokinetics of Paclitaxel in patients with solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2006; 12:2150-7.
01.04.2006Quantitative effect of gender, age, liver function, and body size on the population pharmacokinetics of Paclitaxel in patients with solid tumors
01.04.2006Clinical cancer research : an official journal of the American Association for Cancer Research 2006; 12:2150-7
Jörger Markus, Huitema Alwin D R, van den Bongard Desiree H J G, Schellens Jan H M, Beijnen Jos H
Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometry
Brouwers E, Tibben M, Jörger M, van Tellingen O, Rosing H, Schellens J, Beijnen J. Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometry. Analytical and bioanalytical chemistry 2005; 382:1484-90.
01.08.2005Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometry
01.08.2005Analytical and bioanalytical chemistry 2005; 382:1484-90
Brouwers E E M, Tibben M M, Jörger Markus, van Tellingen O, Rosing H, Schellens J H M, Beijnen J H
Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma
Jörger M, Huitema A, Meenhorst P, Schellens J, Beijnen J. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma. Cancer chemotherapy and pharmacology 2005; 55:488-96.
01.05.2005Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma
01.05.2005Cancer chemotherapy and pharmacology 2005; 55:488-96
Jörger Markus, Huitema A D R, Meenhorst P L, Schellens J H M, Beijnen J H
Von Hippel-Lindau disease--a rare disease important to recognize
Jörger M, Köberle D, Neumann H, Gillessen Sommer S. Von Hippel-Lindau disease--a rare disease important to recognize. Onkologie 2005; 28:159-63.
01.03.2005Von Hippel-Lindau disease--a rare disease important to recognize
01.03.2005Onkologie 2005; 28:159-63
Jörger Markus, Köberle Dieter, Neumann Hartmut P H, Gillessen Sommer Silke
Letale Polypharmazie bei einem Hypertoniker - Erwiderung
Diethelm M, Jörger M. Letale Polypharmazie bei einem Hypertoniker - Erwiderung. Deutsche medizinische Wochenschrift (1946) 2005; 130:413-414.
17.02.2005Letale Polypharmazie bei einem Hypertoniker - Erwiderung
17.02.2005Deutsche medizinische Wochenschrift (1946) 2005; 130:413-414
Diethelm Markus, Jörger Markus
Hypertriglyceridemia as a possible risk factor for prostate cancer
Wuermli L, Jörger M, Henz S, Schmid H, Riesen W, Thomas G, Krek W, Cerny T, Gillessen Sommer S. Hypertriglyceridemia as a possible risk factor for prostate cancer. Prostate cancer and prostatic diseases 2005; 8:316-20.
01.01.2005Hypertriglyceridemia as a possible risk factor for prostate cancer
01.01.2005Prostate cancer and prostatic diseases 2005; 8:316-20
Wuermli L, Jörger Markus, Henz Samuel, Schmid H-P, Riesen W F, Thomas G, Krek W, Cerny Thomas, Gillessen Sommer Silke
Side Effects of Durgs Annual 28
Jörger M, Hartmann K, Kuhn M. Side Effects of Durgs Annual 28 - Drugs acting on the respiratory tract. In: Side Effects of Durgs Annual 28. Oxford UK: Elsevier; Linacre House Jordan Hill, 2004. ISBN 0444515712.
01.01.2005Side Effects of Durgs Annual 28
01.01.2005Elsevier; Linacre House Jordan Hill, ISBN 0444515712
Jörger Markus, Hartmann K, Kuhn M
Side Effects of Drugs Annual 29
Jörger M, Hartmann K, Kuhn M. Side Effects of Drugs Annual 29 - Drugs acting on the respiratory tract. In: Side Effects of Drugs Annual 29. Oxford UK: Elsevier; Linacre House Jordan Hill, 2004. ISBN 0-444-51986-6.
01.01.2005Side Effects of Drugs Annual 29
01.01.2005Elsevier; Linacre House Jordan Hill, ISBN 0-444-51986-6
Jörger Markus, Hartmann K, Kuhn M
Hypertriglyceridemia as a possible risk factor for prostate cancer
Würmli L, Jörger M, Henz S, Schmid H, Riesen W, Thomas G, Krek W, Cerny T, Gillessen Sommer S. Hypertriglyceridemia as a possible risk factor for prostate cancer. Prostate Cancer Prostatic Dis 2005; 8:316-320.
01.01.2005Hypertriglyceridemia as a possible risk factor for prostate cancer
01.01.2005Prostate Cancer Prostatic Dis 2005; 8:316-320
Würmli LIneta, Jörger Markus, Henz Samuel, Schmid Hans-Peter, Riesen Walter F, Thomas G, Krek W, Cerny Thomas, Gillessen Sommer Silke
Letale Polypharmazie bei einem Hypertoniker
Jörger M, Diethelm M. Letale Polypharmazie bei einem Hypertoniker - Lethal polypharmacy in a patient with arterial hypertension. Deutsche medizinische Wochenschrift (1946) 2004; 129:2714-6.
10.12.2004Letale Polypharmazie bei einem Hypertoniker
10.12.2004Deutsche medizinische Wochenschrift (1946) 2004; 129:2714-6
Jörger Markus, Diethelm Markus
Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy
Gautschi O, Stahel R, Betticher D, Jörger M, Weder W, Ratschiller D, Chassé E, Marx A, Jermann M, Huegli B, Bigosch C, Ziegler A. Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004; 22:4157-64.
15.10.2004Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy
15.10.2004Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004; 22:4157-64
Gautschi Oliver, Stahel Rolf A, Betticher Daniel C, Jörger Markus, Weder Walter, Ratschiller Daniel, Chassé Eveline, Marx Arthur, Jermann Monika, Huegli Barbara, Bigosch Colette, Ziegler Annemarie
Therapeutic drug monitoring of non-anticancer drugs in cancer patients
Jörger M, Schellens J, Beijnen J. Therapeutic drug monitoring of non-anticancer drugs in cancer patients. Methods and findings in experimental and clinical pharmacology 2004; 26:531-45.
01.09.2004Therapeutic drug monitoring of non-anticancer drugs in cancer patients
01.09.2004Methods and findings in experimental and clinical pharmacology 2004; 26:531-45
Jörger Markus, Schellens J H M, Beijnen J H
Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)
Fogliata A, Schefer H, Curti G, Schott A, Zenklusen H, Roth A, Morel P, Gertsch P, Gervaz P, Davis J, Székely G, Burger C, Huser M, Kolotas C, Thalmann G, Guillou L, Jichlinski P, von Briel C, Beer K, Miralbell R, Escudé L, Mollà M, Nouet P, Rouzaud M, Mini R, Kemmerling L, Vetterli D, Lütolf U, Ulmer U, Oehler C, Weber D, Bolsi A, Lomax A, Timmermann B, Goitein G, Verwey J, Pedroni E, Rutz H, Lomax A, Weber D, Luthi F, Pasche P, Bentzen S, Khalil A, Dubois J, Pica A, Stupp R, Stadelmann O, Allaoua M, Kebdani T, Slosman D, Dische S, Cummings B, Van den Bogaert W, Horiot J, Saunders M, Isaak B, Pesce G, Popowski Y, Tebeu P, Matzinger O, Betz M, Corminboeuf F, Bouville S, Özsoy O, Bigler R, Vees H, Girardet C, Abdou M, Huguenin P, Verkooijen H, Bouchardy C, Franzetti A, Richetti A, Presilla S, Motta M, Valley J, Bressan S, Bulling S, Pache G, Merçay A, Major A, Usel M, Ludicke F, Rufibach K, Ries G, Coucke P, Wang H, Pasche G, Do H, Balmer A, Munier F, Jargy C, Dipasquale G, Born E, Szczerba D, Hueber P, Hafner H, Cozzi L, Moeckli R, Boehringer T, Collen T, Laluhovà D, Allemann K, Bründler M, Krayenbühl J, Schoenmaker E, Norton I, Baumert B, Rutz H, Pedroni E, Lin S, Coray A, Nicolini G, Vees H, Martineau P, Gourgou S, Zouhair A, Ozsahin M, Cunat S, Larbouret C, Azria A, Bonny C, Hofstetter B, Tenzer A, Krek W, Lutters G, Evans D, Romieu G, Bodis S, Stahel R, Weder W, Jerman M, Schneiter D, Jörger M, Lardinois D, Taverna C, Kestenholz P, Heuberger J, Pèlegrin A, Pujol P, Zimmer Y, Greiner R, Gruber G, Ametamey S, Bodis S, Zingg D, Jochum W, Vuong V, Honer M, Riesterer O, Mhawech P, Verdan C, Tschanz E, Dulguerov P, Ares C, Pruschy M, Inteeworn N, Stalder D, Streit B, Ganapathipillai S, Aebersold D, Berthou S, Kaser-Hotz B, Gassmann M, Rohrer Bley C, Wergin M, Roos M, Höpfl G, Ohlerth S, Allal A, Behrensmeier F, Thürlimann B, Carbone A, Crivellari D, Collins J, Gol-Ouh R, Lindtner J, Holmberg S, Rudenstam C, Castiglione-Gertsch M, Price K, Nasi M, Bonetti M, Simoncini E, Fey M, Bortoluzzi L, Weitzel M, Kranzbuehler H, Becker M, Taussky D, Azria D, Mirimanoff R, Kramar A, Jeanneret Sozzi W, Goldhirsch A, Coates A, Gelber R, Ueltschi G, Lippold B, Kranzbühler H, Bernier J, Studer G, Landmann C, Mahler F, Greiner R, Taverna C, Stanek N, Ciernik I, Friedrich E, Beer K, Balmer Majno S, Hügli A, Gallino A, Juelke P, Pajic B, Curschmann J, Bieri S, Luthi J, Suleiman M, Bargetzi M, Notter M, Thum P, Resink T, Erne P, Jamshidi P, Hafner H, Mach N. Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO). Strahlenther Onkol 2004; 180 Suppl 1:89-108.
01.06.2004Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)
01.06.2004Strahlenther Onkol 2004; 180 Suppl 1:89-108
Fogliata A, Schefer H, Curti G, Schott A, Zenklusen H, Roth A D, Morel Ph, Gertsch P, Gervaz P, Davis J B, Székely G, Burger C, Huser M, Kolotas C, Thalmann G, Guillou L, Jichlinski P, von Briel C, Beer K, Miralbell R, Escudé L, Mollà M, Nouet P, Rouzaud M, Mini R, Kemmerling L, Vetterli D, Lütolf U M, Ulmer U, Oehler C, Weber D, Bolsi A, Lomax A, Timmermann B, Goitein G, Verwey J, Pedroni E S, Rutz H P, Lomax A J, Weber D C, Luthi F, Pasche P, Bentzen S M, Khalil A A, Dubois J B, Pica A, Stupp R, Stadelmann O, Allaoua M, Kebdani T, Slosman D O, Dische S, Cummings B J, Van den Bogaert W, Horiot J C, Saunders M I, Isaak B, Pesce G, Popowski Y, Tebeu P, Matzinger O, Betz M, Corminboeuf F, Bouville S, Özsoy O, Bigler R, Vees H J, Girardet C, Abdou M, Huguenin P, Verkooijen H, Bouchardy C, Franzetti A, Richetti A, Presilla S, Motta M, Valley J F, Bressan S, Bulling S, Pache G, Merçay A, Major A, Usel M, Ludicke F, Rufibach K, Ries G, Coucke P, Wang H, Pasche G, Do H P, Balmer A, Munier F, Jargy C, Dipasquale G, Born E J, Szczerba D, Hueber P, Hafner H P, Cozzi L, Moeckli R, Boehringer T, Collen T, Laluhovà D, Allemann K, Bründler M-A, Krayenbühl J, Schoenmaker E, Norton I A, Baumert B G, Rutz H, Pedroni E, Lin S, Coray A, Nicolini G, Vees H, Martineau P, Gourgou S, Zouhair A, Ozsahin M, Cunat S, Larbouret C, Azria A, Bonny C, Hofstetter B, Tenzer A, Krek W, Lutters G, Evans D B, Romieu G, Bodis St, Stahel R, Weder W, Jerman M, Schneiter D, Jörger Markus, Lardinois D, Taverna Ch, Kestenholz P, Heuberger J, Pèlegrin A, Pujol P, Zimmer Y, Greiner R H, Gruber G, Ametamey S, Bodis S, Zingg D, Jochum Wolfram, Vuong V, Honer M, Riesterer O, Mhawech P, Verdan C, Tschanz E, Dulguerov P, Ares C, Pruschy M, Inteeworn N, Stalder D, Streit B, Ganapathipillai S, Aebersold D M, Berthou S, Kaser-Hotz B, Gassmann M, Rohrer Bley C, Wergin M, Roos M, Höpfl G, Ohlerth S, Allal A S, Behrensmeier F, Thürlimann Beat, Carbone A, Crivellari D, Collins J, Gol-Ouh R, Lindtner J, Holmberg S B, Rudenstam C-M, Castiglione-Gertsch M, Price K N, Nasi M L, Bonetti M, Simoncini E, Fey M F, Bortoluzzi L, Weitzel M, Kranzbuehler H, Becker M, Taussky D, Azria D, Mirimanoff R O, Kramar A, Jeanneret Sozzi W, Goldhirsch A, Coates A S, Gelber R D, Ueltschi G, Lippold B, Kranzbühler H, Bernier J, Studer G, Landmann Ch, Mahler F, Greiner R, Taverna C, Stanek N, Ciernik I F, Friedrich E E, Beer K T, Balmer Majno S, Hügli A, Gallino A, Juelke Peter D, Pajic B, Curschmann J, Bieri S, Luthi J C, Suleiman M, Bargetzi M, Notter M, Thum Peter, Resink Therese Josephine, Erne Paul, Jamshidi Peiman, Hafner Hans-Peter, Mach N
Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer
Jörger M, Warzinek T, Klaeser B, Kluckert J, Schmid H, Gillessen Sommer S. Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 2004; 63:778-80.
01.04.2004Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer
01.04.2004Urology 2004; 63:778-80
Jörger Markus, Warzinek T, Klaeser B, Kluckert J T, Schmid H-P, Gillessen Sommer Silke
Major tumor regression afrer paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer
Jörger M, Warzinek T, Klaeser B, Kluckert J, Schmid H, Gillessen Sommer S. Major tumor regression afrer paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 2004; 63:778-780.
01.04.2004Major tumor regression afrer paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer
01.04.2004Urology 2004; 63:778-780
Jörger Markus, Warzinek T, Klaeser B, Kluckert Jörg-Thomas, Schmid Hans-Peter, Gillessen Sommer Silke
Management and costs of treating lung cancer patients in a university hospital
Dedes K, Szucs T, Bodis S, Jörger M, Lowy A, Russi E, Steinert H, Weder W, Stahel R. Management and costs of treating lung cancer patients in a university hospital. PharmacoEconomics 2004; 22:435-44.
01.01.2004Management and costs of treating lung cancer patients in a university hospital
01.01.2004PharmacoEconomics 2004; 22:435-44
Dedes Konstantin J, Szucs Thomas D, Bodis Stephan, Jörger Markus, Lowy Adam, Russi Erich W, Steinert Hans C, Weder Walter, Stahel Rolf A
Malignant liver tumors: Current and emerging therapies
Pestalozzi B, Jörger M. Malignant liver tumors: Current and emerging therapies - Systematic treatment of hepatobiliary tumors. In: Malignant liver tumors: Current and emerging therapies. 2nd editionJones and Bartlett Publishers, 2003. ISBN 9780763718572. S. 91-99.
01.01.2003Malignant liver tumors: Current and emerging therapies
01.01.2003Jones and Bartlett Publishers, ISBN 9780763718572
Pestalozzi BC, Jörger Markus
Side Effects of Drugs Annual 26
Kuhn M, Jörger M, Hartmann K. Side Effects of Drugs Annual 26 - Drugs acting on the respiratory tract. In: Side Effects of Drugs Annual 26. Oxford UK: Elsevier; Linacre House Jordan Hill, 2003. ISBN 0-444-50999-2.
01.01.2003Side Effects of Drugs Annual 26
01.01.2003Elsevier; Linacre House Jordan Hill, ISBN 0-444-50999-2
Kuhn M, Jörger Markus, Hartmann K